Position in CTKB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$742,436
+$265,600 QoQ
Shares Held
167,593
+53.6% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#43
of 154 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTKB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,102,577 across 41 Medical Devices names. CTKB ranks #17 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in CTKB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $742,436 | 167,593 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $476,836 | 109,116 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $378,570 | 109,098 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $119,564 | 35,166 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $317,038 | 79,062 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $209,877 | 37,884 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $81,730 | 14,647 | Shares | Sole | 2024-08-15 | |
| 2022-06-30 | $791,262 | 73,743 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||